Transesophageal echocardiography (TEE) offers an invaluable, non-invasive avenue for diagnosing and managing various cardiac conditions, including atrial fibrillation (AF). As the most common cardiac arrhythmia, AF affects millions and can lead to severe complications.

Cardioversion, a procedure to restore the heart’s normal rhythm, is frequently conducted on AF patients resistant to medication. Due to inconclusive data, TEE’s utility prior to cardioversion in AF patients remains ambiguous.

Understanding TEE’s potential benefits and limitations in this population could significantly influence clinical practice.

This review aims to scrutinize the current literature on the use of TEE before cardioversion in AF patients.

The principal objective is to understand TEE’s potential benefits and limitations comprehensively.

The study seeks to offer a clear understanding and practical recommendations for clinical practice, thereby improving the management of AF patients before cardioversion using TEE.

Read More